Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis

Exclusion Criteria

• •Known allergy to any of the components in the investigational product.
• •Hypersensitivity against glycopyrrolate
• •Secondary hyperhidrosis, for example, hyperhidrosis that is secondary to other underlying diseases including hyperthyroidism, lymphoma and malaria, climacteric hyperhidrosis.
• •Previous surgical treatment of hyperhidrosis including sympathectomy, surgical debulking of the sweat glands, subcutaneous tissue curettage and ultrasonic surgery.
• •Botulinum toxin treatment in the prior 4 months.
• •Angle closure glaucoma or its precipitation (narrow angle).
• •Mycotic, other skin infections and other dermal disorder including infection at anticipated application sites in either axilla.
• •Any condition or situation that, in the investigator's or sub-investigator's opinion, may interfere with the patient's participation in the study